Radical radiation therapy for lung cancer.
Radical radiotherapy of lung cancer has been studied for over 30 years. Results of early trials are often cited to justify a wait-and-see approach for all nonresectable patients. Because of more accurate staging, better radiotherapy treatment planning and delivery, and recognition of nonanatomic prognostic factors, a 2-year survival rate of 20 to 30% is being credibly reported by national cooperative groups. Radical radiotherapy for lung cancer is a sophisticated process. Treatment planning to maximize the therapeutic ratio, adequate hardware, and an understanding and minimization of radiation complications are all necessary to optimize treatment.
Seagren
S L
SL
Division of Radiation Oncology, University of California, San Diego Medical School.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy* / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011836:Radiation Tolerance; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents